Spirobarbital
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
1-ethyl-2,4-dimethyl-7,9-diazaspiro[4.5]decane-6,8,10-trione
|
|
| Identifiers | |
| CAS Number | 12262-77-0  Y |
| ATC code | none |
| UNII | LR477QH2IL Y |
| Synonyms | 5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid |
| Chemical data | |
| Formula | C12H18N2O3 |
| Molecular mass | 238.282 g/mol |
|
|
| (verify) | |
Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]
References
- ↑ US Patent 2561688
- ↑ Isbell H, Chrusciel TS. Dependence Liability of Non-Narcotic Drugs. Bulletin of the World Health Organisation 1970; 43: Supplement.
| GABAA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| GABAB | |||||||||
| H1 |
|
||||||||
| α2-Adrenergic | |||||||||
| 5-HT2A |
|
||||||||
| Melatonin | |||||||||
| Orexin | |||||||||
| Others | |||||||||
|
|||||||||
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Barbiturates
- Spiro compounds
- GABAA receptor positive allosteric modulators
- Nervous system drug stubs
Hidden category:
